Austin Beck, MD
Family Medicine · Benton, KYNPI 1245641273
Payments from drug & device makers
Across 259 payments — averaging $28.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- AbbVie$602
- Lilly USA, LLC$557
- Abbott$552
- Amgen$455
- Boehringer Ingelheim$343
- plus $2K from 25 others
What the payments were for
- Grants$3,00041%
- Travel & lodging$2573%
- Food & beverage$4,13856%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $3,000 |
| AbbVie(2 entities) | 35 | $602 |
| Lilly USA, LLC | 39 | $557 |
| Abbott | 8 | $552 |
| Amgen(2 entities) | 35 | $455 |
| Boehringer Ingelheim | 24 | $343 |
| Novo Nordisk | 22 | $299 |
| AstraZeneca | 12 | $297 |
| Pfizer | 25 | $292 |
| Otsuka America Pharmaceutical, Inc. | 9 | $166 |
| Ironshore Pharmaceuticals Inc. | 3 | $119 |
| Johnson & Johnson | 6 | $97 |
| Bayer | 5 | $79 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| GSK | 4 | $62 |
| Amarin Pharma, Inc. | 4 | $54 |
| Exact Sciences | 3 | $51 |
| Genentech USA, Inc. | 2 | $43 |
| Sunovion Pharmaceuticals Inc. | 3 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Alkermes, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 2 | $23 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Novartis | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$3,000
- PROCLAIM$374
- FARXIGA$162
- SYMBICORT$162
How this compares
$7,401 in reported general payments places this provider in the 90th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 180 | $271,828 |
| MounjaroTirzepatide | 156 | $204,709 |
| JardianceEmpagliflozin | 137 | $144,551 |
| TrulicityDulaglutide | 90 | $127,215 |
| EliquisApixaban | 166 | $124,147 |
| XareltoRivaroxaban | 120 | $96,280 |
| FarxigaDapagliflozin Propanediol | 83 | $80,232 |
| EntrestoSacubitril/Valsartan | 43 | $46,187 |
| Spiriva RespimatTiotropium Bromide | 51 | $32,326 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 13 | $31,971 |
| JanuviaSitagliptin Phosphate | 29 | $28,521 |
| LinzessLinaclotide | 30 | $24,849 |
| NuedextaDextromethorphan Hbr/Quinidine | 30 | $20,399 |
| Nurtec OdtRimegepant Sulfate | 14 | $19,087 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 76 | $14,848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $557 | $331,925246 claims |
| Novo NordiskOzempic, Xultophy 100-3.6 | $299 | $303,800193 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $343 | $176,877188 claims |
| PfizerEliquis, Nurtec Odt | $292 | $143,233180 claims |
| Johnson & JohnsonXarelto, Invokana | $97 | $107,043134 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $297 | $89,78694 claims |
| NovartisEntresto | $18 | $46,18743 claims |
| AbbVieLinzess | $602 | $24,84930 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $62 | $21,66639 claims |
| Sanofi-aventis U.S. LLCMultaq, Soliqua 100-33 | $23 | $15,89623 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $27 | $11,67419 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $10,68817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Benton
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.